2024
Association between cannabis use and brain structure and function: an observational and Mendelian randomisation study
Ishrat S, Levey D, Gelernter J, Ebmeier K, Topiwala A. Association between cannabis use and brain structure and function: an observational and Mendelian randomisation study. BMJ Mental Health 2024, 27: e301065. PMID: 39477366, PMCID: PMC11529520, DOI: 10.1136/bmjment-2024-301065.Peer-Reviewed Original ResearchConceptsCannabis useBrain structuresFunctional connectivityHistory of cannabis useResting-state functional connectivityMeasures of brain structureLifetime cannabis useCentral executive networkLifetime cannabis usersWhite matter integrityGenu of the corpus callosumMendelian randomisation analysisAssociated with multiple measuresPoorer white matter integrityInvestigate potential causal relationshipsCannabis usersExecutive networkBrain regionsImaging-derived phenotypesBrain healthCannabisRandomisation analysesTwo-sample Mendelian randomisation analysisFractional anisotropyYoung adulthood
2023
Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses
Collaboration E, Sofianopoulou E, Kaptoge S, Afzal S, Jiang T, Gill D, Gundersen T, Bolton T, Allara E, Arnold M, Mason A, Chung R, Pennells L, Shi F, Sun L, Willeit P, Forouhi N, Langenberg C, Sharp S, Panico S, Engström G, Melander O, Tong T, Perez-Cornago A, Norberg M, Johansson I, Katzke V, Srour B, Sánchez M, Redondo-Sánchez D, Olsen A, Dahm C, Overvad K, Brustad M, Skeie G, Moreno-Iribas C, Onland-Moret N, van der Schouw Y, Tsilidis K, Heath A, Agnoli C, Krogh V, de Boer I, Kobylecki C, Çolak Y, Zittermann A, Sundström J, Welsh P, Weiderpass E, Aglago E, Ferrari P, Clarke R, Boutron M, Severi G, MacDonald C, Providencia R, Masala G, Zamora-Ros R, Boer J, Verschuren M, Cawthon P, Schierbeck L, Cooper C, Schulze M, Bergmann M, Hannemann A, Kiechl S, Brenner H, van Schoor N, Albertorio J, Sacerdote C, Linneberg A, Kårhus L, Huerta J, Imaz L, Joergensen C, Ben-Shlomo Y, Lundqvist A, Gallacher J, Sattar N, Wood A, Wareham N, Nordestgaard B, Di Angelantonio E, Danesh J, Butterworth A, Burgess S. Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. The Lancet Diabetes & Endocrinology 2023, 12: e2-e11. PMID: 38048800, PMCID: PMC7615586, DOI: 10.1016/s2213-8587(23)00287-5.Peer-Reviewed Original ResearchConceptsMendelian randomisation analysisCoronary heart diseaseRandomisation analysesAll-Cause MortalityMortality outcomesFatal ischaemic heart diseaseHeart diseaseIncident coronary heart diseaseHistory of coronary heart diseasePopulation-based cohort studyHealth Data Research UKCause-specific mortality outcomesNational Institute for Health ResearchMendelian randomisation frameworkDose-response relationshipIndividuals of European ancestryRisk of coronary heart diseaseRandomised trials of vitamin D supplementationLow vitamin D statusBritish Heart FoundationCancer Research UKInternational Agency for Research on CancerMiddle-aged individualsIschaemic heart diseaseMedical Research Council8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION
Austin-Zimmerman I, Levey D, Deak J, Galimberti M, Adhikari K, Zhou H, Di Forti M, Polimanti R, Stein M, Gelernter J. 8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION. European Neuropsychopharmacology 2023, 75: s60. DOI: 10.1016/j.euroneuro.2023.08.119.Peer-Reviewed Original ResearchSleep durationMillion Veteran ProgramLong sleepCoronary artery diseaseType 2 diabetesAdequate sleep durationShort sleep durationMajor depressive disorderLong sleep durationSleep duration dataPost-traumatic stress disorderGenome-wide association studiesMendelian randomisation analysisArtery diseaseDisturbed sleepDepressive disorderShort sleepRisk lociHealth outcomesSleep hoursCognitive functionSleepStress disorderRandomisation analysisMendelian randomisation
2019
Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis
Saunders CN, Cornish AJ, Kinnersley B, Law PJ, Claus EB, Il’yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Houlston RS. Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis. Neuro-Oncology 2019, 22: 207-215. PMID: 31665421, PMCID: PMC7442418, DOI: 10.1093/neuonc/noz209.Peer-Reviewed Original ResearchConceptsDensity lipoprotein cholesterolGlioma riskLipoprotein cholesterolRisk factorsHigh-density lipoprotein cholesterolLow-density lipoprotein cholesterolMultiple potential risk factorsInsulin-like growth factor-1Modifiable risk factorsSystolic blood pressureBody mass indexPotential risk factorsSerum immunoglobulin E.Body fat percentageGrowth factor-1Risk of gliomaFatty acid levelsLack of associationMendelian randomisation analysisBlood pressureTotal cholesterolWaist circumferenceHemoglobin levelsInflammatory factorsMass index
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply